Murmurs and Valvular Disease Flashcards
Etiology of mitral stenosis
Most commonly rheumatic, although hx of acute rheumatic fever is now uncommon
[rare causes include congenital MS, calcification of the mitral annulus with extension onto leaflets]
With mitral stenosis, sx most commonly begin in ____ decade, but MS causes severe disability at earlier ages in developing nations
4th
Principle symptoms of mitral stenosis
Dyspnea and pulmonary edema precipitated by exertion, excitement, fever, anemia, tachycardia, pregnancy, sexual intercourse, etc.
Complications of mitral stenosis
Hemoptysis, PE, pulmonary infxn, systemic embolization
Note that systemic endocarditis is uncommon in pure MS
Lab ECG findings with mitral stenosis
Atrial fibrillation or left atrial enlargement when sinus rhythm is resent
Right axis deviation and RV hypertrophy in presence of pulmonary HTN
CXR findings with mitral stenosis
LA and RV enlargement with Kerley B lines
Echocardiogram is most useful noninvasive test for mitral stenosis. What are the typical findings?
Shows reduced separation, calcification, and thickening of valve leaflets and subvalvular apparatus, and LA enlargement
Doppler flow recordings provide estimation of transvalvular gradient, mitral valve area, and degree of pulmonary HTN
Treatment for mitral stenosis
At-risk pts should receive prophylaxis for recurrent rheumatic fever (penicillin V 250-500 mg PO BID or benzathine penicillin G 1-2 M units IM monthly).
In the presence of dyspnea, sodium restriction and oral diuretic therapy; beta blockers, rate-limiting calcium channel blockers (i.e., verapamil or diltiazem), or digoxin to slow ventricular rate in afib. Warfarin (with target INR of 2-3) for pts with afib or hx of thromboembolism. For afib of recent onset, consider conversion (chemical or electrical) to sinus rhythm, ideally after > 3 weeks AC therapy.
Mitral valvotomy in the presence of symptoms and mitral orific < 1.5cm. In uncomplicated MS, percutaneous balloon valvuloplasty is the procedure of choice; if not feasible, then open surgical valvotomy.
Etiology of mitral regurg
Mitral valve prolapse, rheumatic heart disease, ischemic heart disease with papillary muscle dysfunction, LV dilation of any cause, mitral annular calcification, hypertrophic cardiomyopathy, IE, congenital
Echocardiogram findings with mitral regurg
Enlarged LA, hyperdynamic LV, identifies mechanism of MR; Doppler analysis helpful in dx and assessment of severity & degree of pulmonary HTN
Treatment for mitral regurg
For severe/decompensated MR, treat as for heart failure. IV vasodilators (e.g., nitroprusside) are beneficial for acute, severe MR. AC is indicated in the presence of afib.
For chronic pulmonary MR, surgical tx — either valve repair or replacement — is appropriate if pt has symptoms or evidence of progressive LV dysfunction (e.g., LV ejection fraction [LVEF] < 60% or end-systolic LV diameter by echo > 40 mm). Operation should be carried out before development of chronic heart failure symptoms. Pts with functional ischemic MR may require coronary artery revascularization along with valve repair.
Functional nonischemic MR d/t LV enlargement with impaired contractile function should be treated with aggressive heart failure therapies and consideration of cardiac resynchronization therapy.
Etiology of MVP
Most commonly idiopathic
May accompany Marfan or EDS
Pathology associated with MVP
Redundant mitral valve tissue with myxedematous degeneration and elongated chordae tendinae
Most imporant complication of MVP
Progressive MR; rarely, systemic emboli from platelet-fibrin deposits on valve
Sudden death is very rare outcome
Treatment for MVP
Asymptomatic pts should be reassurd
Beta blockers may lessen chest discomfort and palpitations
Prophylaxis for infective endocarditis is indicated only if prior hx of endocarditis
Valve repair or replacement for pts with severe mitral regurg; ASA or AC therapy for pts with hx of TIA or embolization
PE findings with mitral stenosis
Right ventricular lift; palpable S1; opening snap (OS) follows A2 by 0.06=0.12 seconds; OS-A2 interval inversely proportional to severity of obstruction
Diastolic rumbling murmur with presystolic accentuation when in sinus rhythm, best heard in left lateral decubitus position
Duration of murmur correlates with severity of obstruction
Other: may see malar rash or blue facies
Clinical manifestations with mitral regurg (including sx and PE findings)
Sx: Fatigue, weakness, and exertional dyspnea
Physical exam:
Sharp low-volume upstroke of carotid arterial pulse, LV lift, S1 diminished: wide splitting of S2; S3 common; loud holosystolic murmur at apex (less than holosystolic in acute severe MR) and often a brief early-mid-diastolic murmur d/t increased transvalvular flow